Hanson Pharmaceuticals (03692) announced that Li Xinying has resigned as the company's joint company secretary and will no longer serve as the Hong Kong Joint Stock Company...
Zhitong Finance App News, Hanson Pharmaceuticals (03692) announced that Li Xinying has resigned as the company's joint company secretary and is no longer acting as the company's authorized representative under section 3.05 of the Hong Kong Stock Exchange Limited Securities Listing Rules and the authorized representative of the company (legal procedure document agent) representing the company under section 19.05 (2) of the Listing Rules and Part 16 of the Companies Ordinance (Chapter 622 of the Hong Kong Laws of China) (Legal Procedure Documents Agent), which will take effect from April 29, 2024.
Tan Sihui has been appointed as Joint Company Secretary with effect from April 29, 2024.
Following Li Xinying's resignation, he has also ceased acting as an authorized representative and agent for legal proceedings since April 29, 2024. The board of directors announced that Tan Sihui, who was newly appointed as the joint company secretary, has been appointed as an authorized representative and agent for legal proceedings, effective April 29, 2024. Since April 29, 2024, the authorized representatives and legal process documents agents are Sun Yuan and Tan Sihui.